Posts tagged with: "Avandia" Results 161 - 180 of 887
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
18 Mar 2008, 7:41 am
" Avandia is a drug developed by GlaxoSmithKline and used to treat Type 2 diabetes. [read post]
20 Apr 2010, 8:20 am by Carey, Danis & Lowe, L.L.C.
If the agency stops the so-called TIDE study -- which compares the safety of Avandia and its competitor Actos -- it could also lead to the removal of Avandia from the U.S. market. [read post]
1 Feb 2011, 7:13 am
As a Fort Worth Avandia Product Recall Attorney, I am providing this latest Avandia lawsuit information. [read post]
26 Oct 2010, 12:28 pm by Mark Zamora
The maker of Avandia -- GSK --- has received from the Department of Justice more than one subpoena. [read post]
9 Jun 2009, 1:27 pm
Nissen, and others about  what the RECORD study shows about the safety of Avandia, and what it does not. [read post]
24 Mar 2010, 3:51 am by Bob Kraft
A disturbing report by the Mayo Clinic alleges that about 90% of the scientists who published articles supporting GlaxoSmithKline's diabetes drug Avandia had financial ties to the company, as reported by Bloomberg News. [read post]
17 Aug 2007, 5:04 pm
Article on cnn.com -- Avandia, Actos to include 'black box' warnings, by the Associated Press. [read post]
8 Jun 2009, 6:04 pm
Article in the Wall Street Journal -- Diabetes Study Questions Expensive Treatments: NIH Finds Patients With Heart Disease Fare Equally Well Without Stents and Drugs Such as Avandia, Actos, by Keith J. [read post]
15 Dec 2007, 5:19 pm
She had no prior heart problems or any type of heart disease prior to taking Avandia. [read post]
15 Jul 2010, 5:06 pm
Johann-Liang left the FDA in 2007 after recommending that Glaxo add additional warnings and information to Avandia's label about the risks Avandia posed to heart health. [read post]
15 Jul 2010, 5:06 pm by Anapol Schwartz
Johann-Liang left the FDA in 2007 after recommending that Glaxo add additional warnings and information to Avandia's label about the risks Avandia posed to heart health. [read post]
12 Jul 2010, 4:45 am by Mark Zamora
Avandia should be pulled from the market because of the "serious" cardiovascular risk the diabetes drug poses, which exceeds that of competitor pioglitazone (Actos), FDA staff reviewers again recommended.Rosiglitazone is no more effective at improving glycemic control in type 2 diabetes than pioglitazone and provides no known unique health benefits, and while both drugs increase the risk of congestive heart failure, rosiglitazone's effect is "substantially greater,"… [read post]
10 Jan 2012, 1:44 pm by LaBovick Law
Avandia cases are getting ready to settle or explode: GlaxoSmithKlien is ready to either pay out or be bleed to death in Avandia cases. [read post]
24 Jan 2011, 5:35 am by Schachtman
Despite adding Avandia to metformin, doubling the doses of Avandia, doubling and then quadrupling doses of metformin, Mr. [read post]